Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was ...

Cognitive impairment is common in untreated MS patients, affecting 1 in 4, with rates particularly higher in those with SPMS, ...